炎症营养复合指标及评分在肺癌预后评估中的研究进展
Research Progress on Inflammatory Nutrition Composite Index and Score in Prognostic Assessment of Lung Cancer
DOI: 10.12677/acm.2026.1651918, PDF,    科研立项经费支持
作者: 雷 浠:贵州医科大学临床医学院,贵州 贵阳;杨华军*:贵州医科大学附属兴义医院呼吸与危重症医学科,贵州 兴义
关键词: 肺癌预后炎症营养指标评分Lung Cancer Prognosis Inflammation Nutrition Index Score
摘要: 肺癌是全球范围内发病率和死亡率持续居高不下的恶性肿瘤,多数患者在确诊时已处于晚期,严重影响了疾病的预后。目前,临床医生主要使用TNM分期系统来评估患者预后,但该方法存在一定的局限性。研究表明,炎症水平和营养状态在肺癌的发生、发展和预后中具有重要意义,并且相关指标及评分与肺癌的预后存在显著相关性。本文综述了炎症和营养复合指标及评分与肺癌预后之间的关联,旨在为临床医生选择合适的预后指标或评分提供参考,并对未来的研究方向进行展望。
Abstract: Lung cancer is a malignant tumor characterized by persistently high incidence and mortality rates globally. Most patients are diagnosed at advanced stages, which severely impacts the prognosis of the disease. Currently, clinicians primarily utilize the TNM staging system to assess patient prognosis; however, this method has certain limitations. Research indicates that levels of inflammation and nutritional status significantly influence the occurrence, progression, and prognosis of lung cancer, with relevant indexes and scores being strongly correlated with patient outcomes. This article reviews the association between inflammation and nutrition composite indexes and scores and the prognosis of lung cancer, aiming to provide reference for clinicians to choose appropriate prognostic indexes or scores, and look forward to future research directions.
文章引用:雷浠, 杨华军. 炎症营养复合指标及评分在肺癌预后评估中的研究进展[J]. 临床医学进展, 2026, 16(5): 1187-1194. https://doi.org/10.12677/acm.2026.1651918

参考文献

[1] Xia, C., Dong, X., Li, H., Cao, M., Sun, D., He, S., et al. (2022) Cancer Statistics in China and United States, 2022: Profiles, Trends, and Determinants. Chinese Medical Journal, 135, 584-590. [Google Scholar] [CrossRef] [PubMed]
[2] Li, C., Lei, S., Ding, L., Xu, Y., Wu, X., Wang, H., et al. (2023) Global Burden and Trends of Lung Cancer Incidence and Mortality. Chinese Medical Journal, 136, 1583-1590. [Google Scholar] [CrossRef] [PubMed]
[3] Molina, J.R., Yang, P., Cassivi, S.D., Schild, S.E. and Adjei, A.A. (2008) Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship. Mayo Clinic Proceedings, 83, 584-594. [Google Scholar] [CrossRef
[4] Reinfeld, B.I., Madden, M.Z., Wolf, M.M., Chytil, A., Bader, J.E., Patterson, A.R., et al. (2021) Cell-Programmed Nutrient Partitioning in the Tumour Microenvironment. Nature, 593, 282-288. [Google Scholar] [CrossRef] [PubMed]
[5] Kraemer, A.I., Chong, C., Huber, F., Pak, H., Stevenson, B.J., Müller, M., et al. (2023) The Immunopeptidome Landscape Associated with T Cell Infiltration, Inflammation and Immune Editing in Lung Cancer. Nature Cancer, 4, 608-628. [Google Scholar] [CrossRef] [PubMed]
[6] Alberici Pastore, C., Paiva Orlandi, S. and González, M.C. (2013) Association between an Inflammatory-Nutritional Index and Nutritional Status in Cancer Patients. Nutricion Hospitalaria, 28, 188-193.
[7] Chen, X., Wu, Q., Gong, W., Ju, S., Fan, J., Gao, X., et al. (2024) GRP75 Triggers White Adipose Tissue Browning to Promote Cancer-Associated Cachexia. Signal Transduction and Targeted Therapy, 9, Article No. 253. [Google Scholar] [CrossRef] [PubMed]
[8] Yue, M., Qin, Z., Hu, L. and Ji, H. (2024) Understanding Cachexia and Its Impact on Lung Cancer and Beyond. Chinese Medical Journal Pulmonary and Critical Care Medicine, 2, 95-105. [Google Scholar] [CrossRef] [PubMed]
[9] Lu, T. and Li, W. (2025) Neutrophil Engulfment in Cancer: Friend or Foe? Cancers, 17, Article No. 384. [Google Scholar] [CrossRef] [PubMed]
[10] Dai, S., Ren, P., Ren, J., Yang, L. and Li, W. (2021) The Relationship between Lymphocyte Subsets and the Prognosis and Genomic Features of Lung Cancer: A Retrospective Study. International Journal of Medical Sciences, 18, 2228-2234. [Google Scholar] [CrossRef] [PubMed]
[11] Best, M.G., Wesseling, P. and Wurdinger, T. (2018) Tumor-Educated Platelets as a Noninvasive Biomarker Source for Cancer Detection and Progression Monitoring. Cancer Research, 78, 3407-3412. [Google Scholar] [CrossRef] [PubMed]
[12] Tang, Q., Li, X. and Sun, C. (2024) Predictive Value of Serum Albumin Levels on Cancer Survival: A Prospective Cohort Study. Frontiers in Oncology, 14, Article ID: 1323192. [Google Scholar] [CrossRef] [PubMed]
[13] El‐Khatib, M., Duncan, H.J. and Kant, K.S. (2006) Role of C‐Reactive Protein, Reticulocyte Haemoglobin Content and Inflammatory Markers in Iron and Erythropoietin Administration in Dialysis Patients. Nephrology, 11, 400-404. [Google Scholar] [CrossRef] [PubMed]
[14] Maslyanko, M., Harris, R.D. and Mu, D. (2021) Connecting Cholesterol Efflux Factors to Lung Cancer Biology and Therapeutics. International Journal of Molecular Sciences, 22, Article No. 7209. [Google Scholar] [CrossRef] [PubMed]
[15] Zhu, M., Ma, Z., Zhang, X., Hang, D., Yin, R., Feng, J., et al. (2022) C-Reactive Protein and Cancer Risk: A Pan-Cancer Study of Prospective Cohort and Mendelian Randomization Analysis. BMC Medicine, 20, Article No. 301. [Google Scholar] [CrossRef] [PubMed]
[16] Bo, Y., Yao, M., Zhang, L., et al. (2015) Preoperative Nutritional Risk Index to Predict Postoperative Survival Time in Primary Liver Cancer Patients. Asia Pacific Journal of Clinical Nutrition, 24, 591-597.
[17] Ramos, R., Nadal, E., Peiró, I., Masuet-Aumatell, C., Macia, I., Rivas, F., et al. (2018) Preoperative Nutritional Status Assessment Predicts Postoperative Outcomes in Patients with Surgically Resected Non-Small Cell Lung Cancer. European Journal of Surgical Oncology, 44, 1419-1424. [Google Scholar] [CrossRef] [PubMed]
[18] Xie, H., Ruan, G., Zhang, Q., Ge, Y., Song, M., Zhang, X., et al. (2022) Combination of Nutritional Risk Index and Handgrip Strength on the Survival of Patients with Cancer Cachexia: A Multi-Center Cohort Study. Journal of Inflammation Research, 15, 1005-1015. [Google Scholar] [CrossRef] [PubMed]
[19] Shen, F., Ma, Y., Guo, W. and Li, F. (2022) Prognostic Value of Geriatric Nutritional Risk Index for Patients with Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. Lung, 200, 661-669. [Google Scholar] [CrossRef] [PubMed]
[20] Li, J., Zhu, N., Wang, C., You, L., Guo, W., Yuan, Z., et al. (2023) Preoperative Albumin-to-Globulin Ratio and Prognostic Nutritional Index Predict the Prognosis of Colorectal Cancer: A Retrospective Study. Scientific Reports, 13, Article No. 17272. [Google Scholar] [CrossRef] [PubMed]
[21] Xia, H., Zhang, W., Zheng, Q., Zhang, Y., Mu, X., Wei, C., et al. (2023) Predictive Value of the Prognostic Nutritional Index in Advanced Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis. Heliyon, 9, e17400. [Google Scholar] [CrossRef] [PubMed]
[22] Ryu, H., Song, C., Kim, J., Jeon, J.H., Cho, S., Kim, K., et al. (2023) Role of Prognostic Nutritional Index in Postoperative Radiotherapy for Non‐small Cell Lung Cancer. Thoracic Cancer, 14, 2859-2868. [Google Scholar] [CrossRef] [PubMed]
[23] Oku, Y., Toyokawa, G., Wakasu, S., Kinoshita, F., Takamori, S., Watanabe, K., et al. (2023) Impact of the Pretreatment Prognostic Nutritional Index on the Survival after First‐Line Immunotherapy in Non‐Small‐Cell Lung Cancer Patients. Cancer Medicine, 12, 14327-14336. [Google Scholar] [CrossRef] [PubMed]
[24] Jafri, S.H., Shi, R. and Mills, G. (2013) Advance Lung Cancer Inflammation Index (ALI) at Diagnosis Is a Prognostic Marker in Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC): A Retrospective Review. BMC Cancer, 13, Article No. 158. [Google Scholar] [CrossRef] [PubMed]
[25] Song, M., Zhang, Q., Song, C., Liu, T., Zhang, X., Ruan, G., et al. (2022) The Advanced Lung Cancer Inflammation Index Is the Optimal Inflammatory Biomarker of Overall Survival in Patients with Lung Cancer. Journal of Cachexia, Sarcopenia and Muscle, 13, 2504-2514. [Google Scholar] [CrossRef] [PubMed]
[26] Yamaguchi, O., Kaira, K., Imai, H., Mouri, A., Shiono, A., Miura, Y., et al. (2024) Clinical Utility of Inflammatory and Nutritious Index as Therapeutic Prediction of Nivolumab Plus Ipilimumab in Advanced Non-Small Cell Lung Cancer. Oncology, 102, 271-282. [Google Scholar] [CrossRef] [PubMed]
[27] Tang, Y., Ji, Y. and Yang, M. (2022) Prognostic Value of Pre-Treatment Advanced Lung Cancer Inflammation Index in Non-Small Cell Lung Cancer: A Meta-Analysis. Biomarkers, 27, 441-447. [Google Scholar] [CrossRef] [PubMed]
[28] Lu, Z., Fu, S., Li, W., Gao, X. and Wang, J. (2024) Prognostic Role of C‐Reactive Protein to Albumin Ratio in Lung Cancer: An Updated Systematic Review and Meta‐Analysis. Chronic Diseases and Translational Medicine, 10, 31-39. [Google Scholar] [CrossRef] [PubMed]
[29] Gradel, K.O. (2023) Interpretations of the Role of Plasma Albumin in Prognostic Indices: A Literature Review. Journal of Clinical Medicine, 12, Article No. 6132. [Google Scholar] [CrossRef] [PubMed]
[30] Deng, T., Zhang, J., Zhou, Y. and Li, W. (2018) The Prognostic Value of C-Reactive Protein to Albumin Ratio in Patients with Lung Cancer. Medicine, 97, e13505. [Google Scholar] [CrossRef] [PubMed]
[31] Matsubara, T., Takamori, S., Haratake, N., Fujishita, T., Toyozawa, R., Ito, K., et al. (2021) Identification of the Best Prognostic Marker among Immunonutritional Parameters Using Serum C-Reactive Protein and Albumin in Non-Small Cell Lung Cancer. Annals of Surgical Oncology, 28, 3046-3054. [Google Scholar] [CrossRef] [PubMed]
[32] Güç, Z.G., Alacacıoğlu, A., Kalender, M.E., Oflazoğlu, U., Ünal, S., Yıldız, Y., et al. (2022) HALP Score and GNRI: Simple and Easily Accessible Indexes for Predicting Prognosis in Advanced Stage NSCLC Patients. the İzmir Oncology Group (IZOG) Study. Frontiers in Nutrition, 9, Article ID: 905292. [Google Scholar] [CrossRef] [PubMed]
[33] Shen, X., Zhang, Y., Wang, W. and Pan, Y. (2019) The Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score in Patients with Small Cell Lung Cancer before First-Line Treatment with Etoposide and Progression-Free Survival. Medical Science Monitor, 25, 5630-5639. [Google Scholar] [CrossRef] [PubMed]
[34] Huo, J., Wang, Y., Su, J., Liu, S., Osoegawa, A., Jia, Z., et al. (2024) Correlation of Hemoglobin, Albumin, Lymphocyte, and Platelet Score with Prognosis in Patients with Stage III Squamous Lung Cancer. Journal of Thoracic Disease, 16, 7016-7028. [Google Scholar] [CrossRef] [PubMed]
[35] Matsukawa, T., Suto, K., Kanaya, M., Izumiyama, K., Minauchi, K., Yoshida, S., et al. (2020) Validation and Comparison of Prognostic Values of GNRI, PNI, and CONUT in Newly Diagnosed Diffuse Large B Cell Lymphoma. Annals of Hematology, 99, 2859-2868. [Google Scholar] [CrossRef] [PubMed]
[36] Liu, H., Yang, X., Liu, D., Tong, C., Wen, W. and Chen, R. (2023) Clinical Significance of the Controlling Nutritional Status (CONUT) Score in Gastric Cancer Patients: A Meta-Analysis of 9,764 Participants. Frontiers in Nutrition, 10, Article ID: 1156006. [Google Scholar] [CrossRef] [PubMed]
[37] Zhang, C., Li, X., Cong, Z., Zheng, C., Luo, C., Xie, K., et al. (2021) Controlling Nutritional Status Is a Prognostic Factor for Patients with Lung Cancer: A Systematic Review and Meta-Analysis. Annals of Palliative Medicine, 10, 3896-3905. [Google Scholar] [CrossRef] [PubMed]
[38] Lee, S.C., Lee, J.G., Lee, S.H., Kim, E.Y., Chang, J., Kim, D.J., et al. (2020) Prediction of Postoperative Pulmonary Complications Using Preoperative Controlling Nutritional Status (CONUT) Score in Patients with Resectable Non-Small Cell Lung Cancer. Scientific Reports, 10, Article No. 12385. [Google Scholar] [CrossRef] [PubMed]
[39] Zhang, C., Fan, K., Gao, M. and Pang, B. (2022) Prognostic Value of Glasgow Prognostic Score in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. Pathology and Oncology Research, 28, Article ID: 1610109. [Google Scholar] [CrossRef] [PubMed]
[40] Tanaka, T., Yoshida, T., Masuda, K., Takeyasu, Y., Shinno, Y., Matsumoto, Y., et al. (2023) Prognostic Role of Modified Glasgow Prognostic Score in Elderly Non-Small Cell Lung Cancer Patients Treated with Anti-PD-1 Antibodies. Respiratory Investigation, 61, 74-81. [Google Scholar] [CrossRef] [PubMed]
[41] Zhang, Y., Chen, S., Chen, H. and Li, W. (2023) A Comprehensive Analysis of Glasgow Prognostic Score (GPS)/the Modified Glasgow Prognostic Score (mGPS) on Immune Checkpoint Inhibitor Efficacy among Patients with Advanced Cancer. Cancer Medicine, 12, 38-48. [Google Scholar] [CrossRef] [PubMed]
[42] Kollár, D., Benedek-Tóth, Z., Drozgyik, A., Molnár, F.T. and Oláh, A. (2021) Perioperative Nutritional State as a Surgical Risk in Oncologic Patients. Orvosi Hetilap, 162, 504-513. [Google Scholar] [CrossRef] [PubMed]
[43] Illa, P., Tomiskova, M. and Skrickova, J. (2015) Nutritional Risk Screening Predicts Tumor Response in Lung Cancer Patients. Journal of the American College of Nutrition, 34, 425-429. [Google Scholar] [CrossRef] [PubMed]